800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled Asthma

view all Clinical Trials

Overview

The goal of this study is to assess and compare the effectiveness of fluticasone furoate/umeclidinium bromide/vilanterol trifenatate (FF/UMEC/VI) with inhaled corticosteroids/long-acting beta-2 agonists (ICS/LABA) in adult participants with uncontrolled asthma

Clinical Trial Information

Protocol

TIRB#: 31720

Phase

4

Condition(s)

Asthma

Investigator

Kartik Shenoy, MD

Coordinator

Arwa Mukhtar

Visit clinicaltrials.gov for full description.

Contact

This trial is not currently open for enrollment, but it is expected to re-open at a later date. For more information about this trial or to inquire about eligibility, email [email protected] or call 215-707-1359.

Full Title

A Phase 4, 52-week (Primary Analysis at 24-weeks), Randomized, Stratified, Open-label, Active-controlled, Parallel-group, Effectiveness Study, Comparing FF/UMEC/VI With Non-ellipta Usual Care (ICS/LABA) in Adult Participants With Uncontrolled Asthma